Tag

The Khiron sponsored study found 9 out of 10 patients reported some degree of improvement of their chronic pain.

The 4,000 square foot facility features 11 patient rooms and according to Khiron, can handle 40,000 patient consultations per year.

Khiron has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico.

Q3 2021 revenue increased 83% YoY to $3.5 million compared to the previous year. Continued strong gross margins for medical cannabis segment at 89%

The medical cannabis treatment study shows positive results in more than 80% of participants with only minor side-effects.

Khiron says the report adheres to global reporting initiative (GRI) standards and reflects the alignment of Khiron's goals with the United Nations Sustainable Development Goals.

Khiron plans to launch its Zerenia clinics across Mexico in 2021, building on the success of its vertically integrated model in Colombia and Peru, & leveraging its education partnership with Tecnologico de Monterrey.

Like several other companies in Colombia, Khiron (TSX.V: KHRNF) cultivates and processes cannabis at its agricultural facilities in Ibagué, Tolima. But Khiron takes the unique approach of launching and operating a chain of integrative medical clinics under its Zerenia brand,...

The Medellin clinic, with a grand opening planned for December 8, 2020, will support Khiron´s goal of expanding regional access to the firm’s clinical services and medical cannabis products for patients.

Khiron Life Sciences this week announced that it has received manufacturing quotas from the Colombian TQG that authorize the company to manufacture high-THC whole plant extract for both export and domestic purposes.